| Product Code: ETC6076172 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Andorra Lung Cancer Screening Market Overview |
3.1 Andorra Country Macro Economic Indicators |
3.2 Andorra Lung Cancer Screening Market Revenues & Volume, 2021 & 2031F |
3.3 Andorra Lung Cancer Screening Market - Industry Life Cycle |
3.4 Andorra Lung Cancer Screening Market - Porter's Five Forces |
3.5 Andorra Lung Cancer Screening Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Andorra Lung Cancer Screening Market Revenues & Volume Share, By Age group, 2021 & 2031F |
3.7 Andorra Lung Cancer Screening Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Andorra Lung Cancer Screening Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of early detection of lung cancer |
4.2.2 Technological advancements in lung cancer screening equipment and techniques |
4.2.3 Government initiatives promoting regular lung cancer screening programs |
4.3 Market Restraints |
4.3.1 High cost associated with lung cancer screening procedures |
4.3.2 Limited access to advanced screening facilities in rural areas |
4.3.3 Patient reluctance or fear of undergoing lung cancer screening |
5 Andorra Lung Cancer Screening Market Trends |
6 Andorra Lung Cancer Screening Market, By Types |
6.1 Andorra Lung Cancer Screening Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Andorra Lung Cancer Screening Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Andorra Lung Cancer Screening Market Revenues & Volume, By Low-dose computed tomography (LDCT), 2021- 2031F |
6.1.4 Andorra Lung Cancer Screening Market Revenues & Volume, By X-ray, 2021- 2031F |
6.2 Andorra Lung Cancer Screening Market, By Age group |
6.2.1 Overview and Analysis |
6.2.2 Andorra Lung Cancer Screening Market Revenues & Volume, By 50 and older, 2021- 2031F |
6.2.3 Andorra Lung Cancer Screening Market Revenues & Volume, By Below 50, 2021- 2031F |
6.3 Andorra Lung Cancer Screening Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Andorra Lung Cancer Screening Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Andorra Lung Cancer Screening Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.3.4 Andorra Lung Cancer Screening Market Revenues & Volume, By Others, 2021- 2031F |
7 Andorra Lung Cancer Screening Market Import-Export Trade Statistics |
7.1 Andorra Lung Cancer Screening Market Export to Major Countries |
7.2 Andorra Lung Cancer Screening Market Imports from Major Countries |
8 Andorra Lung Cancer Screening Market Key Performance Indicators |
8.1 Percentage increase in the number of individuals participating in lung cancer screening programs |
8.2 Adoption rate of new technologies in lung cancer screening |
8.3 Average waiting time for individuals to undergo lung cancer screening |
8.4 Number of government-funded initiatives to promote lung cancer screening |
8.5 Rate of early-stage lung cancer detection compared to late-stage detection |
9 Andorra Lung Cancer Screening Market - Opportunity Assessment |
9.1 Andorra Lung Cancer Screening Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Andorra Lung Cancer Screening Market Opportunity Assessment, By Age group, 2021 & 2031F |
9.3 Andorra Lung Cancer Screening Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Andorra Lung Cancer Screening Market - Competitive Landscape |
10.1 Andorra Lung Cancer Screening Market Revenue Share, By Companies, 2024 |
10.2 Andorra Lung Cancer Screening Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |